ES2192669T3 - Uso de proteinas como agentes frente a enfermedades autoinmunes. - Google Patents

Uso de proteinas como agentes frente a enfermedades autoinmunes.

Info

Publication number
ES2192669T3
ES2192669T3 ES97910295T ES97910295T ES2192669T3 ES 2192669 T3 ES2192669 T3 ES 2192669T3 ES 97910295 T ES97910295 T ES 97910295T ES 97910295 T ES97910295 T ES 97910295T ES 2192669 T3 ES2192669 T3 ES 2192669T3
Authority
ES
Spain
Prior art keywords
autoimmune diseases
proteins
agents against
against autoimmune
dysterism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97910295T
Other languages
English (en)
Inventor
Alberto E Panerai
Alberto Bartorelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zetesis SpA
Original Assignee
Zetesis SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI961921 external-priority patent/IT1284555B1/it
Priority claimed from ITMI961922 external-priority patent/IT1284556B1/it
Priority claimed from ITMI961919 external-priority patent/IT1284553B1/it
Priority claimed from ITMI961920 external-priority patent/IT1284554B1/it
Application filed by Zetesis SpA filed Critical Zetesis SpA
Application granted granted Critical
Publication of ES2192669T3 publication Critical patent/ES2192669T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE PROTEINAS EXTRAIDAS CON ACIDO PERCLORICO A PARTIR DE ORGANOS DE ANIMALES, PARA LA PREPARACION DE MEDICAMENTOS ACTIVOS CONTRA ENFERMEDADES AUTOINMUNES, EN PARTICULAR CON ACTIVIDAD CONTRA LA ARTERIOSCLEROSIS, LA ARTRITIS, LA ESCLEROSIS MULTIPLE Y LA DIABETES.
ES97910295T 1996-09-18 1997-09-17 Uso de proteinas como agentes frente a enfermedades autoinmunes. Expired - Lifetime ES2192669T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI961921 IT1284555B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antidiabetici
ITMI961922 IT1284556B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti contro la sclerosi multipla
ITMI961919 IT1284553B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiartritici
ITMI961920 IT1284554B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiaterosclerotici

Publications (1)

Publication Number Publication Date
ES2192669T3 true ES2192669T3 (es) 2003-10-16

Family

ID=27453037

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97910295T Expired - Lifetime ES2192669T3 (es) 1996-09-18 1997-09-17 Uso de proteinas como agentes frente a enfermedades autoinmunes.

Country Status (22)

Country Link
US (2) US6468536B1 (es)
EP (1) EP0928197B1 (es)
JP (1) JP2001501925A (es)
KR (1) KR20000036207A (es)
CN (1) CN1151838C (es)
AR (1) AR009952A1 (es)
AT (1) ATE233569T1 (es)
AU (1) AU723669B2 (es)
BR (1) BR9711499A (es)
CA (1) CA2266346A1 (es)
CZ (1) CZ293926B6 (es)
DE (1) DE69719525T2 (es)
DK (1) DK0928197T3 (es)
ES (1) ES2192669T3 (es)
IL (1) IL129024A0 (es)
NO (1) NO991175D0 (es)
NZ (1) NZ334714A (es)
PL (1) PL188746B1 (es)
PT (1) PT928197E (es)
RU (1) RU2196606C2 (es)
TR (1) TR199900596T2 (es)
WO (1) WO1998011909A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3521382B2 (ja) 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
IT1290828B1 (it) 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
JP3871503B2 (ja) 1999-08-30 2007-01-24 日本たばこ産業株式会社 免疫性疾患治療剤
JP4210454B2 (ja) 2001-03-27 2009-01-21 日本たばこ産業株式会社 炎症性腸疾患治療剤
JP3597140B2 (ja) 2000-05-18 2004-12-02 日本たばこ産業株式会社 副刺激伝達分子ａｉｌｉｍに対するヒトモノクローナル抗体及びその医薬用途
AU2001278436A1 (en) * 2000-06-08 2001-12-17 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
JP4212278B2 (ja) 2001-03-01 2009-01-21 日本たばこ産業株式会社 移植片拒絶反応抑制剤
ITMI20010761A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 per il trattamento e la prevenzione dell'epatite cronica attiva
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
NZ548985A (en) * 2004-01-16 2010-02-26 Cbio Ltd Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024247A (en) * 1971-12-27 1977-05-17 Palolab Pharmaceuticals Corporation Composition and method of using a protein mixture derived from liver
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
FR2688227A1 (fr) * 1992-03-04 1993-09-10 Inst Nat Sante Rech Med Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
ATE233569T1 (de) 2003-03-15
EP0928197B1 (en) 2003-03-05
EP0928197A1 (en) 1999-07-14
CN1151838C (zh) 2004-06-02
JP2001501925A (ja) 2001-02-13
US6468536B1 (en) 2002-10-22
AR009952A1 (es) 2000-05-17
DE69719525D1 (de) 2003-04-10
TR199900596T2 (xx) 1999-06-21
NO991175L (no) 1999-03-10
CZ293926B6 (cs) 2004-08-18
AU4774797A (en) 1998-04-14
CA2266346A1 (en) 1998-03-26
NO991175D0 (no) 1999-03-10
CN1230892A (zh) 1999-10-06
PL188746B1 (pl) 2005-04-29
NZ334714A (en) 2000-08-25
KR20000036207A (ko) 2000-06-26
PT928197E (pt) 2003-06-30
IL129024A0 (en) 2000-02-17
US20030108558A1 (en) 2003-06-12
WO1998011909A1 (en) 1998-03-26
BR9711499A (pt) 1999-08-24
AU723669B2 (en) 2000-08-31
CZ91599A3 (cs) 1999-08-11
RU2196606C2 (ru) 2003-01-20
PL332282A1 (en) 1999-08-30
DK0928197T3 (da) 2003-06-23
DE69719525T2 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
AR015257A1 (es) UNA COMPOSICION ACIDIFICADA Y EL USO DE DICHA COMPOSICION PARA LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO ToPICO DE CONDICIONES DE LAS UNAS Y DE LA PIEL
ES2192669T3 (es) Uso de proteinas como agentes frente a enfermedades autoinmunes.
ES2153106T3 (es) Aminofeniluracilos substituidos como herbicidas e insecticidas.
BR9808255B1 (pt) amidas de ácido aminossalicìlico substituìdas com efeito fungicida, bem como processo para a preparação e uso das mesmas, composições praguicidas, processo para a preparação das mesmas e para combater pragas.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
DE69332856D1 (de) Haarnadelförmiges ribozym
MX27046A (es) 5-arilalquil-4-alcoxy-2(5h)-furanonas, productos intermedios y procedimiento para su preparacion asi como su aplicacion como sustancia activa terapeutica.
ATE272393T1 (de) Rekonstruktion gereinigter membranproteine in vorgefertigten liposomen
ES2139800T3 (es) Preparaciones farmaceuticas liposomales inyectables.
BR0009284B1 (pt) agente para combater pragas animais, bem como seu uso e processo para preparaÇço.
BR9811094A (pt) Agente terapêutico para tumores linfáticos
BR0114043B1 (pt) composiÇço compreendendo combinaÇÕes de substÂncias ativas com propriedades inseticidas e acaricidas, bem como processos para combater pragas animais e para a preparaÇço de composiÇÕes inseticidas e acaricidas.
AU8439998A (en) Compounds
BR0109997B1 (pt) composiÇço compreendendo combinaÇÕes de substÂncias ativas com propriedades inseticidas e acaricidas, emprego e processo para a preparaÇço da referida composiÇço, bem como processo para combater pragas animais.
PT975334E (pt) Microparticulas biodegradaveis para a libertacao sustentada de farmacos terapeuticos
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
ES2137125B1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
BR9913337A (pt) Derivados tan-1057
BR9913389B1 (pt) agentes de preparaÇço, bem como precesso para sua preparaÇço.
ES2156215T3 (es) Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias.
ATE348167T1 (de) Kleines säurelösliches sporenprotein und seine verwendungen
DE50009838D1 (de) Humanes antibiotisches protein
EA199900750A1 (ru) Водная фармацевтическая композиция, включающая активный ингредиент, в высшей степени нерастворимый в воде
BR0009194A (pt) Composição do resorcinol
ES2157419T3 (es) Arilazadioxacicloalquenos substituidos, fungicidas.